Amgen injects £50m in UK gene-sequencing company

19-10-2018

Amgen injects £50m in UK gene-sequencing company

Xesai / iStockphoto.com

Amgen has invested £50 million ($66 million) in Oxford Nanopore Technologies, a UK company specialising in DNA/RNA sequencing technology.


Oxford Nanopore Technologies, Amgen, investment, gene sequencing, DNA, RNA

LSIPR